Women executives who reach the top in finance are reshaping the profession while creating newfound value for their companies, ...
India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...
The students, thereafter, knocked at the doors of Gujarat HC which ordered the BCG to issue the certificate to the students ...
5d
GlobalData on MSNFDA authorises ImmunityBio’s BCG alternative to treat bladder cancerImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...
The Bangladesh Coast Guard continues its regular operations to ensure security in coastal and riverine areas and curb smuggling and drug trafficking. Acting on confidential intelligence, it was ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...
A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...
Canada's agricultural sector is poised to lead a new era of trade diversification, but only if it acts decisively. A new RBC ...
BCG predicts rising temperatures will increase default risk in 30% of agri and housing loans by 2030, highlighting climate ...
India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results